Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1958 1
1959 1
1960 2
1963 1
1964 1
1965 2
1968 1
1969 1
1971 1
1972 2
1974 2
1982 1
1986 1
1997 1
1998 4
2000 2
2001 3
2002 4
2004 1
2005 1
2006 4
2007 7
2008 12
2009 10
2010 12
2011 6
2012 8
2013 10
2014 11
2015 8
2016 6
2017 17
2018 10
2019 5
2020 9
2021 14
2022 10
2023 18
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
EASL Clinical Practice Guidelines on sclerosing cholangitis.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, et al. J Hepatol. 2022 Sep;77(3):761-806. doi: 10.1016/j.jhep.2022.05.011. Epub 2022 Jun 21. J Hepatol. 2022. PMID: 35738507
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.
Bowlus CL, Arrivé L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lunsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis DN. Bowlus CL, et al. Among authors: bergquist a. Hepatology. 2023 Feb 1;77(2):659-702. doi: 10.1002/hep.32771. Epub 2022 Oct 20. Hepatology. 2023. PMID: 36083140 No abstract available.
Reply.
Bergquist A, Stokkeland K, Bottai M. Bergquist A, et al. Clin Gastroenterol Hepatol. 2020 May;18(5):1245-1246. doi: 10.1016/j.cgh.2019.11.021. Epub 2019 Nov 12. Clin Gastroenterol Hepatol. 2020. PMID: 31730911 No abstract available.
Epidemiology of cholangiocarcinoma.
Bergquist A, von Seth E. Bergquist A, et al. Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):221-32. doi: 10.1016/j.bpg.2015.02.003. Epub 2015 Feb 16. Best Pract Res Clin Gastroenterol. 2015. PMID: 25966423 Review.
HLA-DPA1*02:01~B1*01:01 is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cells.
Zecher BF, Ellinghaus D, Schloer S, Niehrs A, Padoan B, Baumdick ME, Yuki Y, Martin MP, Glow D, Schröder-Schwarz J, Niersch J, Brias S, Müller LM, Habermann R, Kretschmer P, Früh T, Dänekas J, Wehmeyer MH, Poch T, Sebode M; International PSC Study Group (IPSCSG); Ellinghaus E, Degenhardt F, Körner C, Hoelzemer A, Fehse B, Oldhafer KJ, Schumacher U, Sauter G, Carrington M, Franke A, Bunders MJ, Schramm C, Altfeld M. Zecher BF, et al. Gut. 2024 Jan 5;73(2):325-337. doi: 10.1136/gutjnl-2023-329524. Gut. 2024. PMID: 37788895 Free PMC article.
Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.
Ji SG, Juran BD, Mucha S, Folseraas T, Jostins L, Melum E, Kumasaka N, Atkinson EJ, Schlicht EM, Liu JZ, Shah T, Gutierrez-Achury J, Boberg KM, Bergquist A, Vermeire S, Eksteen B, Durie PR, Farkkila M, Müller T, Schramm C, Sterneck M, Weismüller TJ, Gotthardt DN, Ellinghaus D, Braun F, Teufel A, Laudes M, Lieb W, Jacobs G, Beuers U, Weersma RK, Wijmenga C, Marschall HU, Milkiewicz P, Pares A, Kontula K, Chazouillères O, Invernizzi P, Goode E, Spiess K, Moore C, Sambrook J, Ouwehand WH, Roberts DJ, Danesh J, Floreani A, Gulamhusein AF, Eaton JE, Schreiber S, Coltescu C, Bowlus CL, Luketic VA, Odin JA, Chopra KB, Kowdley KV, Chalasani N, Manns MP, Srivastava B, Mells G, Sandford RN, Alexander G, Gaffney DJ, Chapman RW, Hirschfield GM, de Andrade M; UK-PSC Consortium; International IBD Genetics Consortium; International PSC Study Group; Rushbrook SM, Franke A, Karlsen TH, Lazaridis KN, Anderson CA. Ji SG, et al. Among authors: bergquist a. Nat Genet. 2017 Feb;49(2):269-273. doi: 10.1038/ng.3745. Epub 2016 Dec 19. Nat Genet. 2017. PMID: 27992413 Free PMC article.
A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis.
Jiang X, Bergquist A, Löscher BS, Venkatesh G, Mold JE, Holm K, Laerdahl JK, Skånland SS, Maleki KT, Cornillet M, Taskén K, Franke A, Karlsen TH, Björkström NK, Melum E. Jiang X, et al. Among authors: bergquist a. Sci Transl Med. 2021 Feb 24;13(582):eabb0036. doi: 10.1126/scitranslmed.abb0036. Sci Transl Med. 2021. PMID: 33627483
Autoimmune liver diseases and diabetes.
Jensen AH, Ytting H, Winther-Sørensen M, Burisch J, Bergquist A, Gluud LL, Wewer Albrechtsen NJ. Jensen AH, et al. Among authors: bergquist a. Eur J Gastroenterol Hepatol. 2023 Sep 1;35(9):938-947. doi: 10.1097/MEG.0000000000002594. Epub 2023 Jun 22. Eur J Gastroenterol Hepatol. 2023. PMID: 37505973
Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis.
Han Y, Byun J, Zhu C, Sun R, Roh JY, Cordell HJ, Lee HS, Shaw VR, Kang SW, Razjouyan J, Cooley MA, Hassan MM, Siminovitch KA, Folseraas T, Ellinghaus D, Bergquist A, Rushbrook SM, Franke A, Karlsen TH, Lazaridis KN; International PSC Study Group; McGlynn KA, Roberts LR, Amos CI. Han Y, et al. Among authors: bergquist a. Nat Commun. 2023 Feb 24;14(1):1069. doi: 10.1038/s41467-023-36678-8. Nat Commun. 2023. PMID: 36828809 Free PMC article.
185 results